Using telehealth to improve buprenorphine access during and after COVID-19: A rapid response initiative in Rhode Island

Despite its proven efficacy, buprenorphine remains dramatically underutilized for management of opioid use disorder largely due to onerous barriers to treatment initiation. During the COVID-19 pandemic, many substance use disorder treatment facilities have reduced their hours and services, exacerbat...

Descripción completa

Detalles Bibliográficos
Autores principales: Clark, Seth A., Davis, Corey, Wightman, Rachel S., Wunsch, Caroline, Keeler, Lee Ann Jordison, Reddy, Neha, Samuels, Elizabeth A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817486/
https://www.ncbi.nlm.nih.gov/pubmed/33771282
http://dx.doi.org/10.1016/j.jsat.2021.108283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817486/
https://www.ncbi.nlm.nih.gov/pubmed/33771282
http://dx.doi.org/10.1016/j.jsat.2021.108283

Ejemplares similares